Surge in low value contracts drive down margins at Bupa Home Healthcare

Further growth in medicines management volumes is continuing to bring mixed fortunes for Bupa Home Healthcare.Turnover surged almost 45% to £388.7m in the year ended 31 December 2014 after the sudden exit of one of the company’s competitors boosted its medicines management volumes. However, delivery of these low value services impacted on overall gross margins,…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?